Evidence map›Paper›PMID 34946760›Full record

ArticleMolecules (Basel, Switzerland)2021

Selection of Promising Novel Fragment Sized

Dmitry A Shulga, Konstantin V Kudryavtsev

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Ensemble Docking as a Tool for the Rational Design of PeptidomimeticInternational journal of molecular sciences · 2024
    Article
  3. Oligopeptide Sortase Inhibitor ModulatesAntibiotics (Basel, Switzerland) · 2022
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Dmitry A ShulgaDepartment of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1/3, 119991 Moscow, Russia.ORCID 0000-0001-6001-1295
Konstantin V KudryavtsevLaboratory of Molecular Pharmacology, Pirogov Russian National Research Medical University, Ostrovityanova Street 1, 117997 Moscow, Russia.ORCID 0000-0002-6363-5842
Lomonosov Moscow State University · RUMoscow Institute of Physics and Technology · RU

Funding

Russian Science Foundation 20-15-00258
6 · The paper itself

Abstract

Sortase A (SrtA) of

Indexed as

Molecular Docking SimulationQuantitative Structure-Activity RelationshipAminoacyltransferasesAnti-Bacterial AgentsBacterial ProteinsCysteine EndopeptidasesEnzyme InhibitorsLigandsMolecular StructurePyrrolidinesStaphylococcus aureusAminoacyltransferasesAnti-Bacterial AgentsBacterial ProteinsCysteine EndopeptidasesEnzyme InhibitorsLigandsPyrrolidinessortase Aantivirulent agentsclassification modeldescriptor selectionfragment-based drug discoverymachine learningmolecular dockingQSARregression modelsmall-molecule drugssortase a inhibitorsStaphylococcus aureusStrA inhibitorsvirtual screening

Identifiers

PMID34946760
PMCPMC8709105
OpenAlexW4200149988

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.